Cargando…
Identification of Novel p53 Pathway Activating Small-Molecule Compounds Reveals Unexpected Similarities with Known Therapeutic Agents
Manipulation of the activity of the p53 tumor suppressor pathway has demonstrated potential benefit in preclinical mouse tumor models and has entered human clinical trials. We describe here an improved, extensive small-molecule chemical compound library screen for p53 pathway activation in a human c...
Autores principales: | Peltonen, Karita, Colis, Laureen, Liu, Hester, Jäämaa, Sari, Moore, Henna M., Enbäck, Juulia, Laakkonen, Pirjo, Vaahtokari, Anne, Jones, Richard J., af Hällström, Taija M., Laiho, Marikki |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946317/ https://www.ncbi.nlm.nih.gov/pubmed/20885994 http://dx.doi.org/10.1371/journal.pone.0012996 |
Ejemplares similares
-
Proteasome Activity Influences UV-Mediated Subnuclear Localization Changes of NPM
por: Moore, Henna M., et al.
Publicado: (2013) -
DNA intercalator BMH-21 inhibits RNA polymerase I independent of DNA damage response
por: Colis, Laureen, et al.
Publicado: (2014) -
Design, Synthesis, and Structure–Activity
Relationships
of Pyridoquinazolinecarboxamides as RNA Polymerase I Inhibitors
por: Colis, Laureen, et al.
Publicado: (2014) -
DNA damage signaling regulates age-dependent proliferative capacity of quiescent inner ear supporting cells
por: Laos, Maarja, et al.
Publicado: (2014) -
Small-Molecule Targeting of RNA Polymerase I Activates a Conserved Transcription Elongation Checkpoint
por: Wei, Ting, et al.
Publicado: (2018)